Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO of Brooks Bell Inc.
Partner at New Enterprise Associates
Biotech companies used to think about how to build enduring companies with soup-to-nuts operations that had everything under one corporate flag, from research to development to manufacturing to marketing. Those models increasingly look like relics. Investors have grown weary of the long timelines, big bucks, and high risk that come with building such organizations. Stung by losses, a number of VCs, entrepreneurs and investors are turning to small core teams that lean heavily on contract firms to try to make biotech more nimble, less capital intensive, and a more attractive industry for investment. Come join Xconomy’s half-day forum for a number of case studies and interactive chats with national leaders who are looking to reinvent the biotech business model.
Registration and Networking: 1:00 – 2:00 pm
Program: 2:00 – 6:00 pm
Networking Reception: 6:00 – 7:00 pm
Regular Registration: $295
Startup Special: $175
Student Registration: $35
Walk-in Registration: $375